{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:26:15Z","timestamp":1791462375109,"version":"4.3.4"},"reference-count":111,"publisher":"Society of Nuclear Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Nucl Med"],"accepted":{"date-parts":[[2025,4,22]]},"published-print":{"date-parts":[[2025,9]]},"DOI":"10.2967\/jnumed.124.269378","type":"journal-article","created":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T15:00:33Z","timestamp":1747926033000},"page":"1323-1330","source":"Crossref","is-referenced-by-count":26,"title":["Rethinking Dosimetry: A European Perspective"],"prefix":"10.2967","volume":"66","author":[{"given":"Johannes","family":"Tran-Gia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Koole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giammarile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Gear","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Deshayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Minguez Gabi\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cremonesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wadsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Bernhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Bardi\u00e8s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvano","family":"Gnesin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Sandstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Garske-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona-Elisabeth R.","family":"Revheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik A.","family":"Verburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Konijnenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd Joachim","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lassmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Stokke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1602","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"key":"2025090310401679000_66.9.1323.1","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.6061\/clinics\/2019\/e835","article-title":"Radionuclide therapy: current status and prospects for internal dosimetry in individualized therapeutic planning","volume":"74","author":"Sapienza","year":"2019","journal-title":"Clinics (Sao Paulo)."},{"key":"2025090310401679000_66.9.1323.2","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-020-0073-9"},{"key":"2025090310401679000_66.9.1323.3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ijrobp.2020.08.035","article-title":"Current status of radiopharmaceutical therapy","volume":"109","author":"St James","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025090310401679000_66.9.1323.4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.semradonc.2020.07.008","article-title":"Dosimetry for optimized, personalized radiopharmaceutical therapy","volume":"31","author":"Graves","year":"2021","journal-title":"Semin Radiat Oncol."},{"key":"2025090310401679000_66.9.1323.5","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.255547"},{"key":"2025090310401679000_66.9.1323.6","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.ijrobp.2020.12.002","article-title":"Overcoming barriers to radiopharmaceutical therapy (RPT): an overview from the NRG-NCI working group on dosimetry of radiopharmaceutical therapy","volume":"109","author":"Divgi","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2025090310401679000_66.9.1323.7","doi-asserted-by":"crossref","first-page":"60S","DOI":"10.2967\/jnumed.121.262977","article-title":"Dosimetry in clinical radiopharmaceutical therapy of cancer: practicality versus perfection in current practice","volume":"62(suppl 3)","author":"Pandit-Taskar","year":"2021","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/14736691211060117","article-title":"ICRU report 96, dosimetry-guided radiopharmaceutical therapy","volume":"21","author":"Sgouros","year":"2021","journal-title":"J ICRU."},{"key":"2025090310401679000_66.9.1323.9","doi-asserted-by":"crossref","first-page":"1218670","DOI":"10.3389\/fchem.2023.1218670","article-title":"Developments in 177Lu-based radiopharmaceutical therapy and dosimetry","volume":"11","author":"George","year":"2023","journal-title":"Front Chem."},{"key":"2025090310401679000_66.9.1323.10","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/mp.16272","article-title":"A persistent belief in radiopharmaceutical therapy","volume":"50(suppl 1)","author":"Sgouros","year":"2023","journal-title":"Med Phys."},{"key":"2025090310401679000_66.9.1323.11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.semradonc.2023.03.011","article-title":"Theranostics and patient-specific dosimetry","volume":"33","author":"Bednarz","year":"2023","journal-title":"Semin Radiat Oncol."},{"key":"2025090310401679000_66.9.1323.12","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267167"},{"key":"2025090310401679000_66.9.1323.13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00259-023-06420-z","article-title":"Toward individualized dosimetry for radiopharmaceutical therapy in day-to-day clinical practice of nuclear oncology: overcoming heterogeneity of radiation-absorbed dose to tumor and critical organs","volume":"51","author":"Bodei","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.14","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.267023"},{"key":"2025090310401679000_66.9.1323.15","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265987"},{"key":"2025090310401679000_66.9.1323.16","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s00259-024-06863-y","article-title":"The LUTADOSE trial: tumour dosimetry after the first administration predicts progression free survival in gastro-entero-pancreatic neuroendocrine tumours (GEP NETs) patients treated with [177Lu]Lu-DOTATATE","volume":"52","author":"Maccauro","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.17","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266991"},{"key":"2025090310401679000_66.9.1323.18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199308123290703"},{"key":"2025090310401679000_66.9.1323.19","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2005.20.195"},{"key":"2025090310401679000_66.9.1323.20","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0761-x"},{"key":"2025090310401679000_66.9.1323.21","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1216-8"},{"key":"2025090310401679000_66.9.1323.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-018-3945-z"},{"key":"2025090310401679000_66.9.1323.23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1159\/000504001","article-title":"177Lu-DOTATATE peptide receptor radionuclide therapy: dose response in small intestinal neuroendocrine tumors","volume":"110","author":"Jahn","year":"2020","journal-title":"Neuroendocrinology."},{"key":"2025090310401679000_66.9.1323.24","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262295"},{"key":"2025090310401679000_66.9.1323.25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1053\/j.semnuclmed.2021.11.001","article-title":"Dosimetric approaches for radioimmunotherapy of non-Hodgkin lymphoma in myeloablative setting","volume":"52","author":"Cicone","year":"2022","journal-title":"Semin Nucl Med."},{"key":"2025090310401679000_66.9.1323.26","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.12.006"},{"key":"2025090310401679000_66.9.1323.27","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262713"},{"key":"2025090310401679000_66.9.1323.28","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264398"},{"key":"2025090310401679000_66.9.1323.29","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264677"},{"key":"2025090310401679000_66.9.1323.30","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00259-023-06536-2","article-title":"Early response monitoring during [177Lu]Lu-PSMA I&T therapy with quantitated SPECT\/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study","volume":"51","author":"Neubauer","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.31","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.124.267955"},{"key":"2025090310401679000_66.9.1323.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.07.1754"},{"key":"2025090310401679000_66.9.1323.33","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s40658-017-0193-4","article-title":"Variations in the practice of molecular radiotherapy and implementation of dosimetry: results from a European survey","volume":"4","author":"Sj\u00f6green Gleisner","year":"2017","journal-title":"EJNMMI Phys."},{"key":"2025090310401679000_66.9.1323.34","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s00259-023-06215-2","article-title":"Results from an EANM survey on time estimates and personnel responsible for main tasks in molecular radiotherapy dosimetry","volume":"50","author":"Gabi\u00f1a","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.35","doi-asserted-by":"crossref","first-page":"103196","DOI":"10.1016\/j.ejmp.2023.103196","article-title":"Implementation of dosimetry for molecular radiotherapy; results from a European survey","volume":"117","author":"Peters","year":"2024","journal-title":"Phys Med."},{"key":"2025090310401679000_66.9.1323.36","unstructured":"Nenot J-C Brenot J Laurier D Rannou A Thierry D . ICRP publication 103: the 2007 recommendations of the International Commission on Radiological Protection. Ann ICRP. 37(2\u20134)."},{"key":"2025090310401679000_66.9.1323.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.08.002"},{"key":"2025090310401679000_66.9.1323.38","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1007\/s12094-022-02798-8","article-title":"Evidence-based guidelines for hypofractionated radiation in breast cancer: conclusions of the Catalan expert working group","volume":"24","author":"Eraso","year":"2022","journal-title":"Clin Transl Oncol."},{"key":"2025090310401679000_66.9.1323.39","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3390\/physics4010017","article-title":"Hadron therapy achievements and challenges: the CNAO experience","volume":"4","author":"Rossi","year":"2022","journal-title":"Physics."},{"key":"2025090310401679000_66.9.1323.40","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.3390\/ijms25052546","article-title":"FLASH radiotherapy: expectations, challenges, and current knowledge","volume":"25","author":"Borghini","year":"2024","journal-title":"Int J Mol Sci."},{"key":"2025090310401679000_66.9.1323.41","first-page":"11S","article-title":"MIRD pamphlet no. 17: the dosimetry of nonuniform activity distributions\u2014radionuclide S values at the voxel level","volume":"40","author":"Bolch","year":"1999","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.42","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.2967\/jnumed.121.262749","article-title":"Dosimetry for radiopharmaceutical therapy: current practices and commercial resources","volume":"62(suppl 3)","author":"Capala","year":"2021","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.43","doi-asserted-by":"crossref","first-page":"20220056","DOI":"10.1259\/bjr.20220056","article-title":"Milestones in dosimetry for nuclear medicine therapy","volume":"95","author":"Gear","year":"2022","journal-title":"Br J Radiol."},{"key":"2025090310401679000_66.9.1323.44","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s00259-022-05934-2","article-title":"An EANM position paper on advancing radiobiology for shaping the future of nuclear medicine","volume":"50","author":"Pouget","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.45","doi-asserted-by":"publisher","DOI":"10.2967\/jnmt.123.265668"},{"key":"2025090310401679000_66.9.1323.46","first-page":"1713","article-title":"Correlation of tumor and whole-body dosimetry with tumor response and toxicity in refractory neuroblastoma treated with 131I-MIBG","volume":"42","author":"Matthay","year":"2001","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.47","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1197-y"},{"key":"2025090310401679000_66.9.1323.48","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.108.053173"},{"key":"2025090310401679000_66.9.1323.49","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.096677"},{"key":"2025090310401679000_66.9.1323.50","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.136044"},{"key":"2025090310401679000_66.9.1323.51","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2824-5"},{"key":"2025090310401679000_66.9.1323.52","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.219352"},{"key":"2025090310401679000_66.9.1323.53","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3390\/cancers14143418","article-title":"Individualization of radionuclide therapies: challenges and prospects","volume":"14","author":"Piwowarska-Bilska","year":"2022","journal-title":"Cancers (Basel)."},{"key":"2025090310401679000_66.9.1323.54","doi-asserted-by":"crossref","first-page":"103188","DOI":"10.1016\/j.ejmp.2023.103188","article-title":"The contest between internal and external-beam dosimetry: The Zeno\u2019s paradox of Achilles and the tortoise","volume":"117","author":"Cicone","year":"2024","journal-title":"Phys Med."},{"key":"2025090310401679000_66.9.1323.55","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40658-020-0282-7","article-title":"EANM Dosimetry Committee series on standard operational procedures for internal dosimetry for 131I mIBG treatment of neuroendocrine tumours","volume":"7","author":"Gear","year":"2020","journal-title":"EJNMMI Phys."},{"key":"2025090310401679000_66.9.1323.56","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1007\/s00259-022-05727-7","article-title":"EANM Dosimetry Committee recommendations for dosimetry of 177Lu-labelled somatostatin-receptor- and PSMA-targeting ligands","volume":"49","author":"Sj\u00f6green Gleisner","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.57","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1007\/s00259-023-06226-z","article-title":"EANM enabling guide: how to improve the accessibility of clinical dosimetry","volume":"50","author":"Gear","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.58","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1007\/s00259-024-06640-x","article-title":"EANM guidance document: dosimetry for first-in-human studies and early phase clinical trials","volume":"51","author":"Stokke","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.59","doi-asserted-by":"publisher","DOI":"10.1118\/1.598063"},{"key":"2025090310401679000_66.9.1323.60","doi-asserted-by":"publisher","DOI":"10.1259\/0007-1285-62-740-679"},{"key":"2025090310401679000_66.9.1323.61","doi-asserted-by":"publisher","DOI":"10.1089\/cbr.2005.20.47"},{"key":"2025090310401679000_66.9.1323.62","doi-asserted-by":"publisher","DOI":"10.1118\/1.2836421"},{"key":"2025090310401679000_66.9.1323.63","doi-asserted-by":"crossref","first-page":"216","DOI":"10.23736\/S1824-4785.16.02744-8","article-title":"Therapeutic schemes in 177Lu and 90Y-PRRT: radiobiological considerations","volume":"61","author":"Sarnelli","year":"2017","journal-title":"Q J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.64","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.119.231480"},{"key":"2025090310401679000_66.9.1323.65","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.211094"},{"key":"2025090310401679000_66.9.1323.66","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2022.01.004"},{"key":"2025090310401679000_66.9.1323.67","first-page":"1168","article-title":"Inhomogeneous localization of radioactivity in the human kidney after injection of [111In-DTPA]octreotide","volume":"45","author":"De Jong","year":"2004","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.68","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.110.075101"},{"key":"2025090310401679000_66.9.1323.69","first-page":"1923","article-title":"Dosimetric framework for therapeutic alpha-particle emitters","volume":"38","author":"Roeske","year":"1997","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.70","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/57\/13\/4403"},{"key":"2025090310401679000_66.9.1323.71","doi-asserted-by":"publisher","DOI":"10.1088\/0031-9155\/57\/10\/3207"},{"key":"2025090310401679000_66.9.1323.72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00411-019-00826-w","article-title":"Internal microdosimetry of alpha-emitting radionuclides","volume":"59","author":"Hofmann","year":"2020","journal-title":"Radiat Environ Biophys."},{"key":"2025090310401679000_66.9.1323.73","doi-asserted-by":"crossref","first-page":"17934","DOI":"10.1038\/s41598-022-22664-5","article-title":"Small-scale (sub-organ and cellular level) alpha-particle dosimetry methods using an iQID digital autoradiography imaging system","volume":"12","author":"Peter","year":"2022","journal-title":"Sci Rep."},{"key":"2025090310401679000_66.9.1323.74","unstructured":"Roadmap for Medical Apps of Ionising Radiation released! EURAMED website. https:\/\/www.euramed.eu\/rocc-n-roll\/roadmap\/. Published March 28, 2024. Accessed April 30, 2025.."},{"key":"2025090310401679000_66.9.1323.75","unstructured":"PRISMAP: building a European network for medical radionuclides. PRISMAP website. https:\/\/www.prismap.eu\/. Accessed April 30, 2025."},{"key":"2025090310401679000_66.9.1323.76","unstructured":"AlphaMet project: metrology for emerging targeted alpha therapies. LinkedIn website. https:\/\/www.linkedin.com\/company\/alphametproject\/. Accessed April 30. 2025."},{"key":"2025090310401679000_66.9.1323.77","first-page":"134","article-title":"Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy","volume":"48","author":"Konijnenberg","year":"2007","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.78","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2020.11.008"},{"key":"2025090310401679000_66.9.1323.79","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1080\/0284186X.2021.1959635","article-title":"Myelosuppression in patients treated with 177lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable","volume":"60","author":"Blakkisrud","year":"2021","journal-title":"Acta Oncol."},{"key":"2025090310401679000_66.9.1323.80","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.122.264953"},{"key":"2025090310401679000_66.9.1323.81","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13550-024-01077-7","article-title":"Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuclide therapy","volume":"14","author":"Persson","year":"2024","journal-title":"EJNMMI Res."},{"key":"2025090310401679000_66.9.1323.82","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.266843"},{"key":"2025090310401679000_66.9.1323.83","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.117.193706"},{"key":"2025090310401679000_66.9.1323.84","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mp.12886","article-title":"Technical note: single time point dose estimate for exponential clearance","volume":"45","author":"Madsen","year":"2018","journal-title":"Med Phys."},{"key":"2025090310401679000_66.9.1323.85","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40658-024-00658-8","article-title":"A review of 177Lu dosimetry workflows: how to reduce the imaging workloads?","volume":"11","author":"Vergnaud","year":"2024","journal-title":"EJNMMI Phys."},{"key":"2025090310401679000_66.9.1323.86","unstructured":"European Commission. Medical Applications of Ionising Radiation for Better Patients\u2019 Lives: A European Research Roadmap. Publications Office of the European Union; 2024."},{"key":"2025090310401679000_66.9.1323.87","doi-asserted-by":"crossref","first-page":"17588359231157632","DOI":"10.1177\/17588359231157632","article-title":"Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials","volume":"15","author":"Jang","year":"2023","journal-title":"Ther Adv Med Oncol."},{"key":"2025090310401679000_66.9.1323.88","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101295"},{"key":"2025090310401679000_66.9.1323.89","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.3390\/cancers13123095","article-title":"Renal safety of [177Lu]Lu-PSMA-617 radioligand therapy in patients with compromised baseline kidney function","volume":"13","author":"Rosar","year":"2021","journal-title":"Cancers (Basel)."},{"key":"2025090310401679000_66.9.1323.90","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265986"},{"key":"2025090310401679000_66.9.1323.91","doi-asserted-by":"publisher","DOI":"10.1016\/0360-3016(91)90171-Y"},{"key":"2025090310401679000_66.9.1323.92","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.02.089"},{"key":"2025090310401679000_66.9.1323.93","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-008-0778-1"},{"key":"2025090310401679000_66.9.1323.94","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-009-1072-6"},{"key":"2025090310401679000_66.9.1323.95","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3193-4"},{"key":"2025090310401679000_66.9.1323.96","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40658-016-0157-0","article-title":"A novel planar image-based method for bone marrow dosimetry in 177Lu-DOTATATE treatment correlates with haematological toxicity","volume":"3","author":"Svensson","year":"2016","journal-title":"EJNMMI Phys."},{"key":"2025090310401679000_66.9.1323.97","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.118.225235"},{"key":"2025090310401679000_66.9.1323.98","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.123.265484"},{"key":"2025090310401679000_66.9.1323.99","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp079"},{"key":"2025090310401679000_66.9.1323.100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/17407745231220661","article-title":"Adaptive phase I\u2013II clinical trial designs identifying optimal biological doses for targeted agents and immunotherapies","volume":"21","author":"Zang","year":"2024","journal-title":"Clin Trials."},{"key":"2025090310401679000_66.9.1323.101","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1200\/JCO.23.01241","article-title":"How can radiopharmaceutical therapies reach their full potential? Improving dose reporting and phase I clinical trial design","volume":"42","author":"Kiess","year":"2024","journal-title":"J Clin Oncol."},{"key":"2025090310401679000_66.9.1323.102","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.112.107524"},{"key":"2025090310401679000_66.9.1323.103","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1007\/s00259-017-3678-4","article-title":"Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry","volume":"44","author":"Sundlov","year":"2017","journal-title":"Eur J Nucl Med Mol I."},{"key":"2025090310401679000_66.9.1323.104","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1007\/s00259-017-3688-2","article-title":"Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: a simulation study","volume":"44","author":"Del Prete","year":"2017","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.105","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1007\/s00259-022-05786-w","article-title":"Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based 177Lu-DOTATATE treatment of NET patients","volume":"49","author":"Sundl\u00f6v","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"2025090310401679000_66.9.1323.106","first-page":"12S","article-title":"Tumor response to radiopharmaceutical therapies: the knowns and the unknowns","volume":"62(suppl 3)","author":"Sgouros","year":"2021","journal-title":"J Nucl Med."},{"key":"2025090310401679000_66.9.1323.107","unstructured":"Council directive 2013\/59\/Euratom of 5 December 2013 laying down basic safety standards for protection against the dangers arising from exposure to ionising radiation, and repealing directives 89\/618\/Euratom, 90\/641\/Euratom, 96\/29\/Euratom, 97\/43\/Euratom and 2003\/122\/Euratom. EUR-Lex website. https:\/\/eur-lex.europa.eu\/eli\/dir\/2013\/59\/oj\/eng. Published January 17, 2014. Accessed April 30, 2025."},{"key":"2025090310401679000_66.9.1323.108","unstructured":"SIMPLERAD. Research4ife website. https:\/\/earl.eanm.org\/simplerad\/. Accessed April 30, 2025."},{"key":"2025090310401679000_66.9.1323.109","unstructured":"Clinical evaluation of therapeutic radiopharmaceuticals in oncology: scientific guideline. European Medicines Agency website. https:\/\/www.ema.europa.eu\/en\/clinical-evaluation-therapeutic-radiopharmaceuticals-oncology-scientific-guideline\/. Published October 11, 2024. Accessed April 30, 2025."},{"key":"2025090310401679000_66.9.1323.110","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.120.246074"},{"key":"2025090310401679000_66.9.1323.111","doi-asserted-by":"crossref","first-page":"103165","DOI":"10.1016\/j.ejmp.2023.103165","article-title":"Future trends for patient-specific dosimetry methodology in molecular radiotherapy","volume":"115","author":"Gustafsson","year":"2023","journal-title":"Phys Med."}],"container-title":["Journal of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.2967\/jnumed.124.269378","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T17:40:36Z","timestamp":1756921236000},"score":1,"resource":{"primary":{"URL":"http:\/\/jnm.snmjournals.org\/lookup\/doi\/10.2967\/jnumed.124.269378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,22]]},"references-count":111,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9,2]]},"published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.2967\/jnumed.124.269378"],"URL":"https:\/\/doi.org\/10.2967\/jnumed.124.269378","relation":{},"ISSN":["0161-5505","2159-662X"],"issn-type":[{"value":"0161-5505","type":"print"},{"value":"2159-662X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,22]]}}}